Teprotumumab, a monoclonal antibody targeted against the insulin-like growth factor 1 (IGF-
1) receptor, was recently approved by the United States Food and Drug Administration for …

Abstract Background and Aims Over the past decade, the DNA methylome has been
increasingly studied in peripheral blood of inflammatory bowel disease [IBD] patients …

This study investigated the therapeutic effects and mechanisms of chitosans (CSs) with
different molecular weights on ulcerative colitis (UC). Three size classes of CSs (Mw≤ 3, 50 …

Importance Proton pump inhibitors (PPIs) are increasingly used during pregnancy; however,
several observational studies have raised concerns about an increased risk of specific types …

Summary Background and Aims To estimate familial aggregation of inflammatory bowel
disease (IBD), we performed a nationwide, case–control study and examined the odds for …

DISCUSSION OAML is a low-grade NHL consisting of small B-cell lymphocytes. Although
only 8% of MALT lymphomas involve the ocular adnexa, OAML constitutes 60%–70% of …

Purpose Family history is one of the strongest risk factors for inflammatory bowel diseases
(IBD) while studies about the clinical phenotype of familial IBD are limited. This study aimed …

Background & Aims Unaffected first-degree relatives (FDRs) from families with≥ 2 affected
FDRs with Crohn's disease (CD, multiplex families) have a high risk of developing CD …

Objective Population‐based studies of the familial aggregation of gout are scarce, and
gene/environment interactions are not well studied. This study was undertaken to evaluate …

Background Research using healthcare administrative data with a validated algorithm can
reveal the real-world data of rare diseases. Aims We investigated an accurate algorithm for …